You are here:

NICE
NICE Guidance
Conditions and diseases
Cancer
Renal cancer

Renal cancer Products

A list of all our products on renal cancer

Filter

Product type
1 selected

Product typePathwaysGuidanceQuality standardsShared learning

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceInterventional procedures guidance

Status

StatusPublishedIn development

New and updated
1 selected

New and updatedNew in the last 6 months

Showing 2 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Pembrolizumab with axitinib for untreated metastatic renal cell carcinoma [ID1426]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
1 April 2020
Avelumab with axitinib for untreated advanced or metastatic renal cell carcinoma [ID1547]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
8 April 2020